Showing results (191-200 of 272) with videos related to
Sort By:
Pageof 28
Nature|August 27, 2010
IkappaBbeta acts to inhibit and activate gene expression during the inflammatory responsePing Rao, Mathew S Hayden, Meixiao Long, et al.Cell Stem Cell|October 7, 2017
Human Embryo Editing: Opportunities and Importance of Transnational CooperationDuanqing Pei, David W Beier, Ephrat Levy-Lahad, et al.Nature Biotechnology|June 30, 2015
Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cellsAyal Hendel, Rasmus O Bak, Joseph T Clark, et al.Nature|November 8, 2016
CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cellsDaniel P Dever, Rasmus O Bak, Andreas Reinisch, et al.Nature Communications|March 31, 2025
Multilayered HIV-1 resistance in HSPCs through CCR5 Knockout and B cell secretion of HIV-inhibiting antibodiesWilliam N Feist, Sofia E Luna, Kaya Ben-Efraim, et al.Cell Reports|December 13, 2018
Heterogeneous Responses of Hematopoietic Stem Cells to Inflammatory Stimuli Are Altered with AgeMati Mann, Arnav Mehta, Carl G de Boer, et al.Immunity|October 5, 2010
MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell developmentRyan M O'Connell, Daniel Kahn, William S J Gibson, et al.Nature Communications|January 29, 2025
Engineering synthetic signaling receptors to enable erythropoietin-free erythropoiesisAadit P Shah, Kiran R Majeti, Freja K Ekman, et al.Gene Therapy|March 13, 2021
Correction of X-CGD patient HSPCs by targeted CYBB cDNA insertion using CRISPR/Cas9 with 53BP1 inhibition for enhanced homology-directed repairColin L Sweeney, Mara Pavel-Dinu, Uimook Choi, et al.Nature Communications|September 8, 2019
Human genome-edited hematopoietic stem cells phenotypically correct Mucopolysaccharidosis type INatalia Gomez-Ospina, Samantha G Scharenberg, Nathalie Mostrel, et al.Pageof 28